Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

298 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-14

Study Completion Date

2019-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if medical, biological, psychological, and social risk factors can be used to develop algorithms that will predict perinatal depression (PND). Data capture will include baseline participant medical, psychological and family history, blood biomarkers, and psychosocial assessments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic Risk Factors Predictive of the Occurrence of Maternally Diagnosed Perinatal Depression in Women

NCT05175755

Perinatal Depression

UNKNOWN NA

Preconception and Pregnancy Obesity Treatment and Prevention Among Women With a History of Depression

NCT03053323

Depression

COMPLETED NA

PreParent: Internet-based Digital Tools to Screen for and Prevent Postpartum Depression in Parents-to-be

NCT07302165

Post-partum Depression

ENROLLING_BY_INVITATION NA

Cohort Study on the Outcome and Influencing Factors of Perinatal Depression

NCT04517981

Perinatal Depression Prognosis

UNKNOWN

A Study of Pregnant and Postpartum Women With and Without Mood Disorders

NCT03615794

Bipolar Disorder Major Depressive Disorder Postpartum Depression +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort 1: Participants between 8 to 14 weeks gestation

Cohort 1 will include female participants who present for the first prenatal visit which takes place between Weeks 8 and 14 at maternity practices associated with University of North Carolina (UNC) Women's Care. Biomarkers, medical and psychiatric history, and psychosocial measures will be evaluated and utilized in developing a predictive risk algorithm for perinatal depression.

No interventions assigned to this group

Cohort 2: Participants between 15 to 36 weeks gestation

Cohort 2 will include female participants enrolled at various points in their pregnancy from Week 15 up through 36 weeks gestation. Biomarkers, medical and psychiatric history, and psychosocial measures will be evaluated and utilized in developing a predictive risk algorithm for perinatal depression.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must be English-speaking and able to understand and follow clinician/researcher/provider recommendations
* Participants must be able to read and comprehend written communications (English) and physically able to complete electronic patient-reported outcome (ePRO) assessments
* Participants must have access to a personal smartphone or a computer and an active personal email address for which they are willing to use for data collection
* Each participant must sign an informed consent form (ICF) indicating that she understands the purpose of and procedures required for this study and is willing to participate in and comply with all procedures in the study
* Participant must be willing and able to have blood draws and to complete the self-reported assessments via mobile electronic device during the study

Exclusion Criteria

* Participant is not English speaking
* Lifetime mood disorder other than major depressive disorder (MDD) (example \[e.g.\], bipolar I) or anxiety disorder
* Lifetime psychotic disorder (eg, schizophrenia, schizoaffective disorder)
* Lifetime alcohol or illicit substance dependence (moderate-severe)
* Current Post-traumatic Stress Disorder (PTSD), significant alcohol or illicit drug use (Ethanol \[ETOH\]/nonprescription drug use) within 12 months greater than or equal to (\>=)occasional use

Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes